Heghine Khachatryan: Lupus Anticoagulant – An Old Concept Revisited with New Mechanistic Insight
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, reposted from Nicola Pozzi on LinkedIn:
“Lupus anticoagulant: an old concept revisited with new mechanistic insight
Recent reflections by Nicola Pozzi remind us that some of the most established concepts in hemostasis and thrombosis still warrant critical re-examination.
In collaboration with Vittorio Pengo, this work revisits lupus anticoagulant from both a historical and mechanistic perspective, integrating emerging insights on antiprothrombin antibodies that have accumulated over recent years.
Why this matters
• Lupus anticoagulant remains a cornerstone laboratory criterion in the diagnosis of antiphospholipid syndrome
• Current testing strategies do not always reflect the underlying biological mechanisms
• New mechanistic data challenge how we interpret and even define what we measure in routine coagulation assays
-This raises an important question:
Is it time to reconsider—and potentially rewrite—parts of our coagulation textbooks?
Progress in science is driven by precisely these moments, when well-established paradigms are revisited in light of robust experimental evidence. Understanding what we measure, why we measure it, and what it truly represents biologically is essential for advancing both diagnostics and patient care.
-Lupus anticoagulant and antiprothrombin antibodies: embracing the future
Journal of Thrombosis and Haemostasis”
Quoting Nicola Pozzi‘s post:
“Hematologists and coagulation enthusiasts—this one’s for you!
Lupus anticoagulant: What is it? How do we measure it? Why does it matter for Antiphospholipid Syndrome (APS)?
Vittorio Pengo and I revisit this highly debated topic with a historical perspective, and share novel mechanistic insights we uncovered in recent years that could reshape how we understand and test for lupus anticoagulant.
Could it be time to rewrite the coagulation textbook? Time (and good science) will tell…”
Title: Lupus anticoagulant and antiprothrombin antibodies: embracing the future
Authors: Vittorio Pengo, Nicola Pozzi

Read also: Danny Hsu and Nicola Pozzi on “Tetra-Positive” APS
-
Jul 21, 2026, 15:02Sham Zamil: The Role of ABO Compatibility in Platelet Pooling
-
Jul 21, 2026, 13:43Dima Shulkin: Assessing AI-Driven Blood Test Screening for Colorectal Cancer
-
Jul 21, 2026, 13:24Benoit Mores: National Initiative Targets Better Cardiovascular Outcomes
-
Jul 21, 2026, 13:10Paolo Zamboni: Chronic Cerebrospinal Venous Insufficiency Hypothesis in Multiple Sclerosis
-
Jul 21, 2026, 13:05Danai Poutakidou։ The Diagnostic Pitfalls of Unexpected PT/INR Prolongation
-
Jul 21, 2026, 13:00Kefah Mokbel: Beyond Thromboprophylaxis – Enoxaparin’s Emerging Anticancer Signal
-
Jul 21, 2026, 12:56Emmanuel Velazquez-Alvarez: Bridging Innovation and Clinical Practice
-
Jul 21, 2026, 12:53Sandrine Bouteille: A Milestone Presentation at ISTH 2026
-
Jul 21, 2026, 12:40Kalled Musallam: A Comprehensive Review of Thalassemia